Where will the market go from here?

[ad_1] Last week was a game changer in global markets. Monday’s announcement from Pfizer and BioNTech of strong results from their late-stage trial for the Covid-19 vaccine surpassed the surge in cases, hospitalizations and deaths caused by the virus. Investors are increasingly looking beyond the next few months. With more …

Read More »

New drug lowers LDL in patients with severe hypercholesterolemia

[ad_1] reviewed by Emily Henderson, Bachelor of Science16 november 2020 The investigational drug evinacumab lowered low-density lipoprotein (LDL) cholesterol, the so-called “bad” cholesterol, by 50 percent in patients with severe hypercholesterolemia whose condition is resistant to standard treatments, a phase 2 study of the Mount Sinai Icahn School of Medicine …

Read More »